Drug Ocean was founded in 2016 as a private company with a focus on selling niche pharmaceutical products supported by strong clinical research and regulatory affairs verticals.
Under the direction of our executive management team, Drug Ocean has benefitted from many combined years of pharmaceutical, commercial, operational, strategic and financial experience. Through different disciplines, we collaborate to build new partnerships and continue development in new directions aimed at continued innovation in drug development, marketing and delivery.
Mr. Ameya Nadkarni
Mr. Michael Bartholomew
Mr. Lou Dretchen